1,899
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Nanomedicine and neurodegenerative disorders: so close yet so far

(Professor) , (Professor) , (Professor) & (Professor)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Min Wei, Zhaofei Yang, Song Li & Weidong Le. (2023) Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach. International Journal of Nanomedicine 18, pages 611-626.
Read now
Giovanni Tosi, J. T. Duskey & Jörg Kreuter. (2020) Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opinion on Drug Delivery 17:1, pages 23-32.
Read now

Articles from other publishers (12)

Rishabh Verma, Ali Sartaj, Farheen Fatima Qizilbash, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Chandra Kala, Md. Shamsher Alam, Sadaf Jamal Gilani & Mohamad Taleuzzaman. (2022) An Overview of the Neuropharmacological Potential of Thymoquinone and its Targeted Delivery Prospects for CNS Disorder. Current Drug Metabolism 23:6, pages 447-459.
Crossref
Ajit Singh, T. Naga Mallika, Bapi Gorain, Awesh K. Yadav, Sanjay Tiwari, S.J.S. Flora, Rahul Shukla & Prashant Kesharwani. (2021) Quantum dot: Heralding a brighter future in neurodegenerative disorders. Journal of Drug Delivery Science and Technology 65, pages 102700.
Crossref
Yutong Zhou, Feiyan Zhu, Yang Liu, Meng Zheng, Yibin Wang, Dongya Zhang, Yasutaka AnrakuYan ZouJia Li, Haigang Wu, Xiaobin PangWei Tao, Olga Shimoni, Ashley I. Bush, Xue Xue & Bingyang Shi. (2020) Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy. Science Advances 6:41.
Crossref
Despoina Eleftheriadou, Despoina Kesidou, Francisco Moura, Eric Felli & Wenhui Song. (2020) Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases. Small 16:43.
Crossref
Shima Masoudi Asil, Jyoti Ahlawat, Gileydis Guillama Barroso & Mahesh Narayan. (2020) Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials Science 8:15, pages 4109-4128.
Crossref
Pablo Vicente Torres-Ortega, Laura Saludas, Amira Sayed Hanafy, Elisa Garbayo & María José Blanco-Prieto. (2019) Micro- and nanotechnology approaches to improve Parkinson's disease therapy. Journal of Controlled Release 295, pages 201-213.
Crossref
Mahendra Rai, Alka Yadav, Avinsh P. Ingle, Anatoly Reshetilov, María José Blanco-Prieto & Chistiane M. Feitosa. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases 1 17 .
Cristina Fornaguera & Maria García-Celma. (2017) Personalized Nanomedicine: A Revolution at the Nanoscale. Journal of Personalized Medicine 7:4, pages 12.
Crossref
Elisa Uliassi, Annachiara Gandini, Rosaria Carmela Perone & Maria Laura Bolognesi. (2017) Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery. Future Medicinal Chemistry 9:10, pages 995-1013.
Crossref
Daniela Silva Adaya, Lucinda Aguirre-Cruz, Jorge Guevara & Emma Ortiz-Islas. (2016) Nanobiomaterials’ applications in neurodegenerative diseases. Journal of Biomaterials Applications 31:7, pages 953-984.
Crossref
Maria Laura Bolognesi, Annachiara Gandini, Federica PratiElisa Uliassi. (2016) From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?. Journal of Medicinal Chemistry 59:17, pages 7759-7770.
Crossref
Dale Stirling. (2016) Improving Human Health at the Atomic Level: A Bibliographic Survey of Nanomedicine. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.